Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...
The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...
Beta-blockers, ACE inhibitors, ARBs, calcium channel blockers linked to higher adverse event rates. HealthDay News — Commonly used noncancer medications, including proton pump inhibitors, are ...
The use of proton pump inhibitors with anti-cancer therapies was associated with worse survival outcomes in patients with breast cancer. Concomitant use of proton pump inhibitors and other everyday ...
NDTV: Sun Pharma Wins Legal Battle Over Pantocid's Name; Uses And Side Effects Of Proton Pump Inhibitors Explained
Sun Pharma Wins Legal Battle Over Pantocid's Name; Uses And Side Effects Of Proton Pump Inhibitors Explained
OregonLive.com: Dear Doctor: If I stop taking proton-pump inhibitors, will I see a ‘rebound effect,’ return of stomach problems?
Dear Doctor: If I stop taking proton-pump inhibitors, will I see a ‘rebound effect,’ return of stomach problems?
Targeting both patients and physicians with information about deprescribing proton pump inhibitors may be more effective than communicating with physicians alone.
Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...
ascopubs.org: Proton pump inhibitors and the risk of adverse renal events and all-cause mortality in cancer patients receiving immune checkpoint inhibitors.